Dibutyltin(IV) Complexes Derived from L-DOPA: Synthesis, Molecular Docking, Cytotoxic and Antifungal Activity


Por: Castillo E.R.-D., Gómez-García O., Andrade-Pavón D., Villa-Tanaca L., Ramírez-Apan T., Nieto-Camacho A., Gómez E.

Publicada: 1 dic 2018
Resumen:
A series of organotin(IV) complexes was herein prepared and characterized. A one-pot synthetic strategy afforded reasonable to high yields, depending on the nature of the ligand. All new complexes were fully characterized by spectroscopic techniques, consisting of IR, MS and NMR (H-1, C-13 and Sn-119). The in vitro cytotoxicity tests demonstrated that the organotin complexes produced a greater inhibition, versus cisplatin (the positive control), of the growth of six human cancer cell lines: U-251 (glioblastoma), K-562 (chronic myelogenous leukemia), HCT-15 (colorectal), MCF-7 (breast), MDA-MB-231 (breast) and SKLU-1 (non-small cell lung). The potency of this cytotoxic activity depended on the nature of the substituent bonded to the aromatic ring. All complexes exhibited excellent IC50 values. The test compounds were also screened in vitro for their antifungal effect against Candida glabrata and Candida albicans, showing minimum inhibitory concentration (MIC) values lower than those obtained for fluconazole. A brine shrimp bioassay was performed to examine the toxic properties. Molecular docking studies demonstrated that the organotin(IV) complexes bind at the active site of topoisomerase I in a similar manner to topotecan, sharing affinity for certain amino acid side chains (11e535, Arg364 and Asp533), as well as for similar DNA regions (DA113, DC112 and DT10).

Filiaciones:
Castillo E.R.-D.:
 Instituto de Química, Universidad Nacional Autónoma de México (UNAM), Circuito Exterior s/n, CiudadUniversitaria, Ciudad de México, 04510, Mexico

Gómez-García O.:
 Departamento de Química Orgánica, Laboratorio de Síntesis deFármacos Heterocíclicos, Escuela Nacional de Ciencias Biológicas-Instituto Politécnico Nacional, Prolongaciónde Carpio y Plan de Ayala S/N, Colonia Santo Tomás 11340, Ciudad de México, Mexico

Andrade-Pavón D.:
 Departamentode Microbiología-Laboratorio de Biología Molecular de Bacterias y Levaduras, Escuela Nacional de CienciasBiológicas-Iinstituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, Colonia Santo Tomás11340, Ciudad de México, Mexico

Villa-Tanaca L.:
 Departamentode Microbiología-Laboratorio de Biología Molecular de Bacterias y Levaduras, Escuela Nacional de CienciasBiológicas-Iinstituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala S/N, Colonia Santo Tomás11340, Ciudad de México, Mexico

Ramírez-Apan T.:
 Instituto de Química, Universidad Nacional Autónoma de México (UNAM), Circuito Exterior s/n, CiudadUniversitaria, Ciudad de México, 04510, Mexico

Nieto-Camacho A.:
 Instituto de Química, Universidad Nacional Autónoma de México (UNAM), Circuito Exterior s/n, CiudadUniversitaria, Ciudad de México, 04510, Mexico

Gómez E.:
 Instituto de Química, Universidad Nacional Autónoma de México (UNAM), Circuito Exterior s/n, CiudadUniversitaria, Ciudad de México, 04510, Mexico
ISSN: 00092363
Editorial
PHARMACEUTICAL SOC JAPAN, 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN, Japón
Tipo de documento: Article
Volumen: 66 Número: 12
Páginas: 1104-1113
WOS Id: 000452247600002
ID de PubMed: 30504627